The Pink Ceiling Launches Today

By The Pink Ceiling, Special for  USDR

 The Pink Ceiling, launching today, is a unique all-women team formed to work alongside mission-driven companies with novel solutions for challenges affecting women. Investments will be made if The Pink Ceiling team becomes an extension of the partner company working to bring their advance to  market.

“My driving passion is identifying real solutions that can become catalysts for meaningful change for women,” said Cindy Whitehead, The Pink Ceiling founder and CEO. “Whether these advances break down social barriers or bust through ceilings to create new categories, our goal is to fuel the solutions that put the power of choice in women’s hands. That was the mission of Sprout with Addyi and this new venture allows me to continue to do the work I  love.”

The Pink Ceiling’s first partnership is with Undercover Colors, a Raleigh-based startup that is developing a wearable nail technology to detect date rape drugs in spiked drinks, providing a powerful tool at the fingertips of women. Undercover Colors was developed in 2014 by four engineering students at North Carolina State University. The company has been focused on the research and development of its technology to  date.

Businesses interested in working with Cindy and her team submit a “pink pitch” for consideration. Pitches aligned with the mission of The Pink Ceiling will be considered for investment and strategic  support.

For more information on The Pink Ceiling and making a pitch, visit www.thepinkceiling.com. Follow via Twitter  @cindypinkceo.

ABOUT THE PINK  CEILING
The Pink Ceiling, founded in 2016 by Cindy Whitehead, will offer strategic consulting or seed investing and commercial support for startups breaking through for women. Providing operational guidance and go-to market strategy, the team will operate as an extension of their clients. For more information on The Pink Ceiling, visit  www.thepinkceiling.com.

ABOUT CINDY  WHITEHEAD
Cindy Whitehead is a leading women’s health advocate and entrepreneur. With a 22-year track record in healthcare, Whitehead is best known for building and selling pharmaceutical businesses that deliver industry record-setting returns. She co-founded and last served as CEO for Sprout Pharmaceuticals. In 2015, the company broke through with the first ever FDA-approved drug, Addyi, for low sexual desire in women – dubbed “female Viagra” by the media. Sprout was sold for a $1B upfront payment. Cindy previously co-founded, led operations and successfully sold Slate Pharmaceuticals, which commercialized the first FDA approved long acting testosterone in the field of sexual  medicine.

Entrepreneur Magazine recently featured Cindy on the cover of their 2016 “Women to Watch” feature. Her breakthrough work has been featured across all major media outlets: The New York Times, Associated Press, Financial Times, CNBC, CBS, Fox, Yahoo, etc. She has spoken at the Fast Company Innovation Festival, Fortune’s Next Gen Most Powerful Women Summit, Chicago Ideas Week and others.  She is actively involved in mentoring young entrepreneurs.  @cindypinkCEO

SOURCE The Pink  Ceiling

All opinions expressed on USDR are those of the author and not necessarily those of US Daily Review.